GSK stock falls as Berenberg raises its price target

Published on 09/23/2026 at 11:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK stock traded at GBX 1,906 on September 23, 2026, down 0.26 percent, while Berenberg raised its target to GBX 2,200. July EPS was GBX 10.80.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK plc (GB0009252882) traded at GBX 1,906 on the London Stock Exchange at 11:35 a.m. on September 23, 2026, down GBX 5 or 0.26 percent from the previous close. The move contrasts with Berenberg's upgrade from Hold to Buy and its price-target increase from GBX 2,000 to GBX 2,200 on September 22, 2026.

Berenberg lifts target to GBX 2,200

According to IT BOLTWISE on September 23, 2026, Berenberg moved GSK from Hold to Buy and raised its target from GBX 2,000 to GBX 2,200. The new target is GBX 294 above the September 23 quotation and GBX 282 above the September 21 closing reference of GBX 1,911 cited in the report.

The broker's longer-range model assigns GSK revenue of GBP 39 billion in 2031, according to IT BOLTWISE. That forecast is a valuation input rather than a reported result, so the market is still weighing pipeline expectations against near-term earnings evidence.

July quarter delivered GBX 10.80 EPS

GSK last reported quarterly results on July 28, 2026, and posted earnings per share of GBX 10.80 for that quarter, according to MarketBeat. The same report lists a 14.52 percent net margin and a 28.35 percent return on equity for the period.

MarketBeat also reports a current-year analyst earnings expectation of 175.980975 pence per share on September 22, 2026. The difference between the July quarterly EPS of GBX 10.80 and the full-year expectation reflects different reporting scopes and should not be treated as a direct quarter-to-year comparison.

Shares remain below the yearly high

The September 23 quotation of GBX 1,906 was below the 50-day moving average of GBX 1,890.22 and the 200-day moving average of GBX 1,953.51 reported by MarketBeat. The stock therefore sat above its shorter-term average but below its longer-term average at the cited market snapshot.

The same September 23 market data showed a market capitalization of GBP 76.47 billion. A separate September 23 report placed the 52-week range at GBX 1,455 to GBX 2,282, leaving the quoted price GBX 376 below the high and GBX 451 above the low.

GSK stock trades at GBX 1,906

GSK stock traded at GBX 1,906 on the London Stock Exchange at 11:35 a.m. on September 23, 2026, with a day range of GBX 1,881 to GBX 1,913.50 and volume of 5.14 million shares. The price action places the shares between the reported 52-week low of GBX 1,455 and high of GBX 2,282.